POST Online Media Lite Edition



 

Medgenics names Barbara Duncan to board

Staff writer |
Philadelphia, Pa., USA - June 11, 2015, Philadelphia, Pa., USA - Medgenics, Inc., a medical technology and therapeutics company, appoints Barbara Duncan to the company's board of directors, effective July 22, 2015.

Article continues below






Ms. Duncan has served as Chief Financial Officer and Treasurer at Intercept Pharmaceuticals, Inc. since May 2009.

She previously served in a series of positions with increasing responsibilities at DOV Pharmaceuticals, Inc. including as Chief Executive Officer and Treasurer.

Before that, she served as Vice President of Corporate Finance – Global Healthcare at Lehman Brothers Inc. and Director of Corporate Finance at SBC Warburg Dillon Read Inc.

LATEST 5 MOVES FROM Pennsylvania 


What to read next

FedEx: Douglas G. Duncan to retire
Intercept Pharma appoints Sandip Kapadia as CFO
OfficeMax: Chairman and CEO Sam Duncan to retire